Search Results

Sevmash Advances Production of Main Thrust Bearings for Icebreaker "Stalingrad"

Sevmash, a subsidiary of the United Shipbuilding Corporation (USC), is continuing production of the main thrust bearings for the Stalingrad, the sixth serial universal icebreaker of Project 22220. One set of bearings for this vessel comprises three bearing units. Currently, two of these units have been delivered to Workshop 16 for bearing housing machining; the bearing raceways are also being machined and assembled in this workshop. The housing of the third unit is being assembled in the plant's hull welding shop. Meanwhile, in a dedicated area of Sevmash Workshop 4, bearing internal filling operations are underway, including the manufacture of bushings and bearing housings with anti-friction layers and filling with hot Babbitt metal. Each unit requires the installation of 24 bearing housings. This stage is one of the most labor-intensive processes in bearing manufacturing.

2026-08-07

Notice of the National Energy Administration on Issuing the "15th Five-Year" Action Plan for Electric Power Safety Production

Notice of the National Energy Administration on Issuing the "15th Five-Year" Action Plan for Electric Power Safety Production To the energy administrations of all provinces (autonomous regions, and municipalities directly under the central government), the development and reform commissions of relevant provinces (autonomous regions, and municipalities directly under the central government) and the Xinjiang Production and Construction Corps, the Beijing Municipal Urban Management Commission, the Tianjin Municipal Bureau of Industry and Information Technology, the Department of Industry and Information Technology of Liaoning Province, the Shanghai Municipal Commission of Economy and Informatization, the Chongqing Municipal Commission of Economy and Informatization, all dispatched agencies, and enterprise member units of the National Electric Power Safety Production Committee: In order to implement the decisions and arrangements of the Party Central Committee and the State Council on strengthening safety production, coordinate development and safety, deeply practice the new energy security strategy of "Four Revolutions and One Cooperation," consolidate the safety foundation for building a strong energy country, continuously improve the level of electric power safety production, and ensure the safe and stable operation of the power system and reliable power supply, the "15th Five-Year" Action Plan for Electric Power Safety Production is hereby formulated. It is now issued for your implementation.

2026-08-07

Oklo's Groves Isotope Test Reactor Achieves First Criticality

Oklo, a U.S. advanced nuclear technology company, announced on August 6 that its Groves Isotope Test Reactor has achieved a controlled self-sustaining nuclear chain reaction at low power, reaching first criticality. This milestone comes less than a year after the project broke ground. Groves Isotope Test Reactor facility (Image: Groves) The Groves low-power test reactor, located in Lockhart, Texas, is the first reactor to achieve criticality on private land under the U.S. Department of Energy's Reactor Pilot Program. According to Oklo, the facility was built from undeveloped land, completing civil excavation, engineering construction, component fabrication or procurement, fuel configuration, and...

2026-08-07

FAO and IAEA: Nuclear Technologies Are Enhancing Agricultural Production and Food Security

On March 30, 2021, the Food and Agriculture Organization of the United Nations and the International Atomic Energy Agency presented multiple applications of nuclear technologies in agriculture and food security. The two organizations have collaborated for over 50 years in knowledge sharing and capacity building, further strengthening their partnership through the establishment of the Joint FAO/IAEA Centre of Nuclear Techniques in Food and Agriculture. In the field of animal health, nuclear technologies are used for the detection, control, and prevention of transboundary animal diseases and zoonoses. Belize previously had to send animal disease testing samples to overseas laboratories; with support from the Joint FAO/IAEA Centre, the Belize Agricultural Health Authority established a molecular diagnostic laboratory for animal health and adopted real-time polymerase chain reaction (PCR) testing technology. This method can detect animal diseases within 24 hours, helping frontline personnel take rapid prevention and control measures. Recently, the laboratory has also been used to assist in human COVID-19 testing, reflecting the "One Health" concept that animal, human, plant, and environmental health are interconnected.

2021-03-30

South Korea Advances First Domestic Commercial Production of Lu-177 Using Wolsong Heavy Water Reactors

Korea Hydro & Nuclear Power (KHNP) plans to use the heavy water reactors at the Wolsong Nuclear Power Plant to produce, for the first time domestically, the radioisotope lutetium-177 (Lu-177) for cancer treatment. Currently, South Korea relies entirely on imports for this material, which imposes cost pressures and supply instability on local radiopharmaceutical companies such as Cellbion and FutureChem. Industry experts generally believe that domestic production will help build a diversified supply chain and shorten transportation times. The primary goal of this plan is to achieve commercial production of Lu-177, with pilot production expected in 2028 and full-scale production commencing in 2031. Subsequently, KHNP will expand production to include cobalt...

2026-08-06

US Firm Standard Nuclear's Two New TRISO Fuel Plants to Enter Production by 2026, Expanding Independent US Capacity

US nuclear fuel manufacturer Standard Nuclear announced that "major construction is substantially complete" at its two TRISO fuel production facilities, SN-TN in Tennessee and SN-ID in Idaho, and that the US Department of Energy has approved the Preliminary Documented Safety Analysis (PDSA) for both plants. The two facilities share an identical design and are expected to sequentially commence commissioning and licensing before the end of 2026. Authorized under the DOE's "Fuel Line Pilot Program," each plant will initially produce up to 1 metric ton of uranium (MTU) per year of TRISO fuel, with a combined ramp-up target of 5 MTU/year in the long term, forming a tiered supply alongside the company's existing SN-0 facility (0.5 MTU/year) operating in Oak Ridge. Standard Nuclear describes itself as "the only independent TRISO fuel manufacturer in the US," having been restructured from the fuel business of Ultra Safe Nuclear following its bankruptcy in 2024 (with USNC's reactor business acquired by Nano Nuclear). Its operations cover power reactor fuel as well as space and defense radioisotope power sources. The company also participates in the DOE's Fuel Line Pilot and Surplus Plutonium Disposition programs, has been allocated HALEU by the DOE for fuel fabrication, and has established a joint-venture TRISO line at Framatome's NRC-licensed fuel facility in Richland, Washington.

2026-08-06

South Korea advances plan to produce medical isotopes using nuclear power plants, with lutetium-177 targeted for commercial production in 2031

South Korea is advancing plans to industrialize the production of radioisotopes using nuclear power plants, with the medical isotope lutetium-177 (Lu-177) designated as the first commercial target product. Korea Hydro & Nuclear Power stated that it plans to prioritize the commercialization of Lu-177 production, with the potential to later expand the product range to include isotopes such as cobalt-60, tritium-3, and helium-3. Lu-177 is a therapeutic radioisotope widely used in the global radiopharmaceutical market, applicable in radiopharmaceuticals for diseases such as prostate cancer and neuroendocrine tumors. Previously, South Korea relied entirely on imports for its Lu-177 supply. Due to its half-life of approximately 6.6 days, the entire process from production and transportation to drug preparation and patient administration...

2026-08-06

Brazilian nuclear industry company starts fuel production for Angra 2's 22nd refueling

Brazilian Nuclear Industries (INB) has started production of nuclear fuel required for the 22nd refueling of Unit 2 at the Angra Nuclear Power Plant (Angra 2). On July 28, INB completed the assembly of the first fuel assembly at the Nuclear Fuel Factory (FCN) in Resende, Rio de Janeiro State; on July 30, the fuel assembly passed all established quality inspections in the production process and was certified. According to the plan, INB will manufacture a total of 52 fuel assemblies for this refueling. The assembly work is expected to be completed in December 2026 and delivered to Eletronuclear in March 2027. Recently, INB has made progress in several key stages of the nuclear fuel manufacturing chain. On July 28, approximately 240 tons of enriched...

2026-08-05

US Oak Ridge National Laboratory Advances New Process to Boost Californium-252 Production

Oak Ridge National Laboratory (ORNL), under the US Department of Energy, is advancing a new Californium-252 (Cf-252) separation process to address growing market demand. The laboratory stated that this process, developed over nearly a decade of research, is expected to shorten the Cf-252 production cycle by about one week, significantly improving processing efficiency without altering product quality. Californium-252 is a neutron-emitting radioisotope used in nuclear reactor startup, fuel testing for new reactors, as well as in oil well logging, coal analysis, port security, fuel rod scanners, and instrument calibration. ORNL noted that it is the only producer of Cf-252 in the Western world...

2026-08-05

Kazakhstan's Uranium Output Up 9% Year-on-Year in First Half of 2026

Kazatomprom, Kazakhstan's largest uranium producer, reported on August 3 that the country's uranium output increased by 9% year-on-year in the first half of 2026. According to the report, on a 100% basis, uranium oxide (U3O8) production from entities in which the company holds stakes totaled 13,291 tonnes in the first half of this year, up from 12,242 tonnes in the same period of 2025. The 100% basis covers the full production of all entities in which Kazatomprom holds stakes, with a portion of that output potentially attributable to joint venture partners or other third-party shareholders. On an attributable basis, Kazatomprom's uranium production in the first half of 2026 stood at 7,054 tonnes, up 10% year-on-year. This basis only counts the portion of production attributable to Kazatomprom...

2026-08-05

Aternium to Build First U.S. Heavy Water and High-Purity Hydrogen Production Facility in Delaware

Aternium announced on August 4 that it has selected Dover, Delaware, as the site for its first commercial heavy water and electrolytic hydrogen production facility. The company has reached a definitive sales agreement for a parcel within Garrison Oak Technical Park, with the transaction expected to close by mid-Q4 2026. The project will serve as Aternium's flagship production initiative in the United States, planned to produce heavy water (deuterium oxide) and high-purity hydrogen. According to company disclosures, the project is expected to bring at least $226 million in capital investment to Dover, create dozens of direct and supporting jobs, and generate hundreds of construction jobs during the build-out phase...

2026-08-05

ASP Isotopes PET Lab Revenue Grows Over 50% in First Half of Year, Isotope Enrichment Facilities Advance Toward Commercial Production

ASP Isotopes Inc. recently released a letter to shareholders outlining operational progress across its business segments ahead of the company's second-quarter 2026 financial results announcement. The company stated that its PET lab segment achieved organic revenue growth of more than 50% in the first half of 2026 compared to the same period in 2025. Based on current expectations, the segment's full-year 2026 revenue is projected to be approximately $14 million, up from $6 million in 2025. PET-related operations are typically closely associated with radiopharmaceutical preparation, molecular imaging, and nuclear medicine diagnostic applications. On the isotope front, ASP Isotopes stated that its silicon-28 and ytterbium-176 enrichment facilities have entered the final stage before commercial production, with first deliveries expected in the second half of 2026...

2026-08-05

Nuvora Completes Independent Review of Pre-Feasibility Study for 300 MWth High-Temperature Gas-Cooled Reactor Hydrogen Production

Nuvora Energy, Inc., a U.S. developer of advanced modular nuclear energy and clean hydrogen infrastructure, announced on August 3 that it has completed a pre-feasibility study for the integration of a 300 MWth prismatic high-temperature gas-cooled reactor with a solid oxide electrolyzer cell hydrogen island, along with an independent third-party review conducted by DBD International. The pre-feasibility study report, titled "Pre-Feasibility Study for Integrated Power Generation and Hydrogen Production Using a 300 MWth High-Temperature Gas-Cooled Reactor," was released in May 2026, with revision number R01. DBD International was commissioned to conduct an independent review of the study and issued its review report, revision B, on May 20, 2026...

2026-08-05

X-energy and SGL Carbon to Expand Nuclear-Grade Graphite Production Capacity

X-Energy and SGL Carbon announced on August 3 that they have signed a binding agreement to expand production capacity for NBG-18 medium-grained isotropic nuclear-grade graphite. NBG-18 is a critical specialty material for X-Energy's Xe-100 high-temperature gas-cooled reactor, supporting the company's subsequent commercial project deployments. Under the agreement, X-Energy will invest up to $8 million in phases to support the construction of new facilities and equipment upgrades at SGL Carbon's plant in Chedde, France. Upon completion of the expansion, the plant will be capable of producing graphite billets annually sufficient for up to eight Xe-100 reactors. SGL Carbon has also agreed to expand its graphite billet processing capacity in the United States to enhance the stability of this safety-critical material supply chain.

2026-08-04

Thor Medical Launches Commercial Production of Lead-212 at AlphaOne Facility

Thor Medical ASA announced on July 31 that commercial production has commenced at its industrial-scale AlphaOne production facility located in the Herøya industrial park. The facility will produce lead-212 (Pb-212) and its precursors thorium-228 (Th-228) and radium-224 (Ra-224) to support demand related to radiopharmaceuticals and targeted cancer radiotherapy. According to the company, Thor Medical has signed supply agreements with multiple types of customers across the radiopharmaceutical value chain, including startup biotechnology companies, contract development and manufacturing organizations (CDMOs), and global pharmaceutical companies. The company expects the AlphaOne facility to deliver its first products to customers in August 2026. AlphaOn...

2026-08-01